CausalSentinel

Protein Dossier — IMPDH2 (Inosine-5’-monophosphate dehydrogenase 2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Height -0.0502 0.00803 4.10e-10 Wald ratio 1 trans NA
Platelet count -3.65 1.08 7.25e-04 Wald ratio 1 trans NA
PGC cross-disorder traits -0.102 0.0329 0.00193 Wald ratio 1 trans NA
Mean platelet volume 0.00803 0.00276 0.00362 Wald ratio 1 trans NA
Weight -0.0164 0.00581 0.00487 Wald ratio 1 trans NA
Bipolar disorder -0.17 0.0637 0.00775 Wald ratio 1 trans NA
Major depressive disorder -0.152 0.0594 0.0104 Wald ratio 1 trans NA
Non-cancer illness code self-reported: hayfever or allergic rhinitis 0.0639 0.0254 0.0118 Wald ratio 1 trans NA
Fractured bone site(s): Other bones -0.0694 0.0307 0.0238 Wald ratio 1 trans NA
Eye problems or disorders: Diabetes related eye disease -0.235 0.108 0.0293 Wald ratio 1 trans NA
Knee osteoarthritis -0.155 0.0746 0.0374 Wald ratio 1 trans NA
Clear cell ovarian cancer -0.23 0.112 0.0395 Wald ratio 1 trans NA
…and 101 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-5250_53_3 IMDH2 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

5 association rows across 5 traits (5 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Glycated hemoglobin levels 3e-17 rs11706052 1 GCST90019509 no MR -> candidate analysis
Educational attainment (years of education) 6e-17 rs72624911 1 GCST006442 no MR -> candidate analysis
Creatinine levels 2e-13 rs11706052 1 GCST90019502 no MR -> candidate analysis
Estimated glomerular filtration rate 4e-13 rs11706052 1 GCST90019506 no MR -> candidate analysis
Duration to complete alphanumeric path task (baseline) 8e-12 rs11706052 1 GCST90565839 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 335 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
autosomal dominant dopa-responsive dystonia 0.608 established (curated) no MR -> candidate analysis
Dystonia 0.544 established (curated) no MR -> candidate analysis
dystonic disorder 0.544 established (curated) no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Inosine-5’-monophosphate dehydrogenase 2)
gnomAD constraint pLI=4.6e-06, LOEUF=0.763 — LoF-tolerant
GWAS Catalog 70 unique SNPs / 140 rows
ClinVar 113 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx 2 clinical annotations across 3 drugs

Caveats declared by the tools

Sources

Provenance